Atorvastatin
Description
Atorvastatin is a selective, competitive inhibitor of HMG-CoA reductase. Atorvastatin lowers plasma cholesterol and lipoprotein serum concentrations by inhibiting HMG-CoA reductase and subsequently cholesterol biosynthesis in the liver and increases the number of hepatic LDL receptors on the cell surface for enhanced uptake and catabolism of LDL.
ATC Classification
Trade names
Cyprus
Singapore
Singapore
Austria
Singapore
Austria
Singapore
Cyprus
Australia
Austria
Austria
Austria
Singapore
Singapore
Singapore
Austria
Cyprus
Singapore
Singapore
Cyprus
Australia Canada Cyprus Netherlands Singapore
Australia
Austria
Cyprus
Singapore
Australia
Singapore
Australia
Singapore
Trade names (in combination): ATORVALAN COMP ATOZET CADIVAST CADUET EZEATO EZETAST LIPTRUZET TRINOMIA TRIVERAM
Product Monographs
2D Molecule Structure
3D Molecule Structure
Unique Ingredient Identifier (UNII)
A0JWA85V8F - ATORVASTATIN
CAS Registry Number
134523-00-5 - atorvastatin
SNOMED-CT
373444002 - Atorvastatin (substance)